MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Puma Biotechnology Company Profile (NASDAQ:PBYI)

Consensus Ratings for Puma Biotechnology (NASDAQ:PBYI) (?)
Ratings Breakdown: 3 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $65.75 (119.90% upside)

Analysts' Ratings History for Puma Biotechnology (NASDAQ:PBYI)
Show:
DateFirmActionRatingPrice TargetActions
3/28/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016JPMorgan Chase & Co.Reiterated RatingBuy$105.00 -> $89.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016RBC CapitalDowngradeOutperform -> Sector Perform$103.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Credit SuisseReiterated RatingOutperform$69.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Citigroup Inc.Lower Price TargetBuy$90.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Berenberg BankUpgradeHold -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015Bank of AmericaInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014Leerink SwannBoost Price TargetOutperform$144.00 -> $300.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/2/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha